MedPath

Efficacy of Non Contrast DWI(Diffusion Weighted Imaging) Imaging Compared to DMR-DE

Not Applicable
Completed
Conditions
Heart Attack
Interventions
Procedure: Diffusion Weighted Imaging with MRI scans
Registration Number
NCT01820000
Lead Sponsor
University of Michigan
Brief Summary

Use of MRI and DWI to diagnose cardiac scarring after heart attack.

Detailed Description

To discover new information about MRI (magnetic resonance imaging) called DWI (diffusion weighted imaging) and its ability to diagnose cardiac scarring.

CMR-DE (cardiac MR with delayed contrast enhancement) evaluates if there has been scarring in the heart muscle following a heart attack.

Subjects are injected with a contrast medication that makes the scarring visible if present. To prove the efficacy of DWI (diffusion weighted imaging) to provide the same images that CMR-DE (cardiac magnetic resonance with delayed contrast enhancement) provides.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Males and females 21 years of age and older
  • Healthy volunteers
  • subjects with a prior history of heart attack and prior CMR-DE imaging.
Read More
Exclusion Criteria
  • Women who are pregnant
  • Subjects with GFR < 60 ml/min/1.73m2
  • Subjects with ICD
  • Subjects with coronary stents incompatible with 3T
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diffusion Weighted Imaging with MRI scansDiffusion Weighted Imaging with MRI scansSubjects will undergo a MRI (magnetic resonance imaging) scan where DWI (diffusion weighted imaging) will be performed. Subjects will not receive contrast during this sequence, but will receive contrast as standard MRI protocol.
Primary Outcome Measures
NameTimeMethod
presence and apparent diffusion coefficient (ADC) quantification of scar on (DWI) diffusion weighted imagesingle occurance

Confirm the efficacy of diffusion weighted imaging in providing imaging that shows cardiac scarring without the injection of contrast.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Michigan Hospital

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath